GenomeWeb

HPV Head and Neck Cancer Recurrence Test Data Adds Validation as Naveris Ramps Clinical Launch

HPV Head and Neck Cancer Recurrence Test Data Adds Validation as Naveris Ramps Clinical Launch Mar 24, 2020 | Molika Ashford NEW YORK – Investigators from the University of North Carolina at Chapel Hill have reached a new milestone for their virus-associated oropharyngeal cancer detection assay, publishing validation data for the test, while a startup has begun to provide the test to early adopters. Appearing last month in the Journal of Clinical Oncology, the group’s study confirmed that the liquid…

0
Read More

GENOMEWEB–Liquid Biopsy of HPV DNA Shows Promise for Monitoring Remission in Oral Cancer

Liquid Biopsy of HPV DNA Shows Promise for Monitoring Remission in Oral Cancer Oct 25, 2018 | Molika Ashford NEW YORK (GenomeWeb) – Investigators shared data this week from a small prospective trial of a blood-based method they developed to test patients with human papillomavirus-associated oral cancers for signs of remission or recurrence. The approach, which was spearheaded by researchers at the University of North Carolina and is being commercialized by startup Naveris, would potentially allow doctors to more accurately…

0
Read More